Premium
Call to Action: Finding Solutions for the Drug Shortage Crisis in the United States
Author(s) -
Fox E R,
Tyler L S
Publication year - 2013
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2012.225
Subject(s) - economic shortage , incentive , quality (philosophy) , action (physics) , drug , business , risk analysis (engineering) , medicine , pharmacology , economics , microeconomics , linguistics , philosophy , physics , epistemology , quantum mechanics , government (linguistics)
In their article in this issue of CPT , Woodcock and Wosinska are the first to clearly outline the quality and manufacturing problems causing drug shortages of generic injectables. These authors have focused on the main issue, namely, that manufacturing problems and the lack of incentives for quality products are the primary reasons for most recent shortages of generic injectable drugs. Clinical Pharmacology & Therapeutics (2013); 93 2, 145–147. doi: 10.1038/clpt.2012.225